82
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Insights into the chemical composition of Ocimum forskaolii and O. americanum essential oils and their phytotoxicity

, , , , &
Pages 902-919 | Received 11 Jun 2023, Accepted 15 Aug 2023, Published online: 01 Sep 2023
 

Abstract

The essential oils (EOs) of numerous Ocimum species are well-known. The EOs of O. forskaolii and O. americanum growing naturally in Saudi Arabia are compared chemically in the current study. The GC-MS and GC-FID analysis was used for identification and quantitation of EOs’ chemical components, and the chemometric analysis was used to determine the differences between the two species. Additionally, against the weeds Dactyloctenium aegyptium and Chenopodium murale, the allelopathic potentiality of the two EOs was assessed. Fifty-one compounds were assigned as overall O. forskaolii EO’ components, with abundance of mono- and sesquit-terpenes (40.49 and 55.15%, respectively). endo-Fenchol (18.15%), tau-cadinol (11.42%), β-atlantol (10.54%), α-eudesmol (7.29%), and α-terpineol (6.94%) were the major components. Sixty-one components were identified via the GC-MS analysis of O. americanum EO, with sesquiterpenes (81.24%) serving as the major class. α-Bulnesene (10.17%), germacrene B (7.72%), endo-borneol (5.51%), isoshyobunone (5.37%), and γ-eudesmol (5.31%) represented the main compounds. Chemometric study showed a distinct difference between the two species’ chemical make-up of the EOs, which might be attributed to genetic changes. The extracted EOs of O. forskaolii and O. americanum demonstrated a significant allelopathic effect against the weeds D. aegyptium and C. murale. Compared to O. americanum, O. forskaolii EO demonstrated greater allelopathic activity. The main components of each species may be a candidate for the observed allelopathic activity, which may act singularly or in combination.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.